Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
In addition, on page 43, paragraph five should read:
"Mean age at the time of follow-up testing was 4.9 years (range: 14 months--13 years). Mean initial screening BLL
was 8.1 µg/dL (range: 2--28
µg/dL), performed 7--77 days (median: 22 days) after arrival. Mean follow-up BLL was 18.6
µg/dL (range: 10--63 µg/dL), performed 35--188 days (median: 89 days) after arrival. Follow-up BLLs increased for 35 of 37 children; the average increase was 11 µg/dL (range: 1--59
µg/dL), and 26 (70.2%) became elevated after the initial testing. Three
children received chelation therapy for BLLs >45
µg/dL."
Also on page 43, paragraph seven should read:
"Blood lead testing identified five additional refugee children with elevated BLLs, but data for these children were
not included in this study because the children did not have both an initial and a follow-up blood lead test. For these five children, mean age at time of blood lead test was 2.4 years (range: 11 months--4 years), and tests were performed 117--190 days after arrival in New Hampshire. Mean BLL was 33.8
µg/dL (range: 17--72 µg/dL). One child, who had a BLL of 72
µg/dL, received chelation therapy immediately."
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
